The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
Hexetidine
In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A01AB12
CAS registry number (Chemical Abstracts Service)
0000141-94-6
Chemical Formula
C21-H45-N3
Molecular Weight
340
Therapeutic Categories
Antiseptic agent
Disinfectant
Chemical Name
5-Pyrimidinamine, 1,3-bis(2-etylhexyl)hexahydro-5-metyl-
Foreign Names
- Hexetidinum (Latin)
- Hexetidin (German)
- Hexétidine (French)
- Hexetidina (Spanish)
Generic Names
- Esetidina (OS: DCIT)
- Hexetidine (OS: BAN)
- Hexétidine (OS: DCF)
- Hexetidin (PH: Ph. Eur. 9)
- Hexetidine (PH: BP 2018, Ph. Eur. 9)
- Hexétidine (PH: Ph. Eur. 9)
- Hexetidinum (PH: Ph. Eur. 9)
Brand Names
- Abrasone [+ Fluocinonide, + Ruscogenin]
Anotaciones Farmaceuticas, Spain - Actiseptic
Johnson & Johnson, Italy - Anso [+ Triamcinolone, + Lidocaine, + Pentosan]
Lacer SA, Hong Kong - Bactidol
Johnson & Johnson, Hong Kong; Johnson & Johnson, Philippines; Johnson & Johnson, Singapore - Belosept
Belupo, Croatia (Hrvatska) - Buchex Forte [+ Benzydamine]
Bernabo, Argentina - Buco
Celsius, Uruguay - Bucosept
Neo-Fármaco, Ecuador - Collu-Hextril
Johnson & Johnson, Portugal - Drossadin 0,1%
Drossapharm, Switzerland - Drossadin 0,2%
Drossapharm, Switzerland - Duphaderm [+ Prednisolone] [veterinary use]
Zoetis, France - Duranil
Elea, Argentina - Ephaldene 0.1%
Western, Egypt - Hekzoton
Drogsan, Turkey - Hexabain
Siphat, Tunisia - Hexadol
Otto Pharmaceutical, Indonesia - Hexalen
Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus - Hexalen 0.1%
Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus - Hexalen 0.2%
Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus - Hexétidine Biogaran Conseil 0.1%
Biogaran, France - Hexétidine EG Labo Conseil 0.1%
EG Labo, France - Hexétidine H2 Pharma 0.1%
H2Pharma, France - Hexétidine Sandoz Conseil 0.1%
Sandoz, France - Hexétidine Teva Conseil 0.1%
Teva Santé, France - Hexocil [veterinary use]
Pharmaxim vet, Finland - Hexoral
Famar Orleans, Georgia; Hemofarm, Bosnia & Herzegowina; Hemofarm AD, Serbia; Janssen-Cilag Pharma, Austria; Johnson & Johnson, Germany; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Latvia; Johnson & Johnson, Russian Federation; Lex ano, Lithuania; McNeil, Estonia; McNeil, Lithuania; McNeil, Romania - Hexoral 0.1g/100ml
Famar Orleans, Bulgaria - Hexoral 0.2g/100ml
Famar Orleans, Bulgaria - Hextend
Hemofarm, Bosnia & Herzegowina - Hextril
Janssen-Cilag, Switzerland; Johnson & Johnson, France; Johnson & Johnson, Portugal; Johnson & Johnson Consumer, Netherlands - Hextril 0.1%
Johnson & Johnson, Belgium; Johnson & Johnson, France - Hextril 0.5%
Johnson & Johnson, France - Hextril 5mg/5ml
Johnson & Johnson, Luxembourg - Isozid-H [+ Propanol]
Gebro Pharma, Austria - Mantus [+ Pentosan Polysulfate, + Triamcinolone, + Lidocaine]
Investi, Argentina - Nifluril [+ Nilfumic Acid]
UPSA, Kuwait - Oraldene
Johnson & Johnson, Ireland; McNeil, Malta; McNeil Products, United Kingdom; Pfizer, Kuwait - Oraldene 0.1%
Parke Davis, Egypt - Oraldine
Johnson & Johnson, Ecuador; Johnson & Johnson, Uruguay; Johnson & Johnson, South Africa - Rinsidin
Pharmaline, Lebanon - Stomatidin
Bosnalijek, Bosnia & Herzegowina; Bosnalijek, Macedonia - Stopangin
Ivax, Slovakia; Teva, Czech Republic - Triocil [veterinary use]
Pharmachem, Australia; Provet, New Zealand - Vagi-Hex
Assos, Turkey; Drossapharm, Switzerland; Drossapharm, Germany
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.